Importantly, we found that metastatic tissues express high levels of nuclear HIF2α, even when the tumor arises from a PPGL lacking mutations in any of the oxygen-sensing related genes associated with PPGL tumorigenesis, thus suggesting that metastatic PPGL could be benefited by therapies targeting HIF2α. The gene discussed is EPAS1; the disease is neoplasm.